MedTrace Logo

Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida

NCT03630770 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-06-14

Study results available
· View outcomes & findings →

Summary

This study evaluates whether adding a dietary supplement similar to coconut oil (MCT oil) to feedings in premature infants will reduce the amount of yeast (Candida) detectable in their stool. Infants who have Candida in their stool are eligible to participate. Half of the enrolled infants will have additional MCT oil added to their feedings and half will not.

Conditions

  • Candida Infection
  • Premature Infant

Interventions

DRUG

Medium-Chain Triglyceride (MCT) Oil

Infants receive 0.5 ml/oz of MCT oil to their prescribed feedings for 21 days or until hospital discharge.

Sponsors & Collaborators

  • Tufts University

    collaborator OTHER

  • Joseph Bliss

    lead OTHER

Principal Investigators

  • Joseph M Bliss, MD, PhD · Women and Infants Hospital of Rhode Island

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-05
Primary Completion
2017-11-29
Completion
2021-11-02
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03630770 on ClinicalTrials.gov